Howard Dickler, M.D.
Chief Operating Officer
Dr. Dickler received his B.A. from the Johns Hopkins University and his M.D. from the George Washington University School of Medicine where he was first in his class. Following training in internal medicine at the New York Hospital – Cornell Medical Center, he did fellowships in immunology at the Rockefeller University under Henry G. Kunkel and at the National Cancer Institute under William D. Terry. He then joined the Immunology Branch of the National Cancer Institute as a Senior Investigator.
His laboratory focused on the characterization of cell surface molecules on lymphocytes and mononuclear cells, the interactions of these molecules on the cell surface, and their role in regulating the immune response. He has authored more than 60 peer-reviewed publications. Dr. Dickler was subsequently appointed Chief of the Clinical Immunology Branch of the National Institute of Allergy and Infectious Diseases, leading a $90 Million extramural research program where he more than doubled research funding supported by the branch and more than tripled support for set-aside initiatives during a time period when support for NIAID programs other than AIDS grew by less than half. He pioneered multi-Institute cooperative funding of initiatives, developed accelerated review and funding mechanisms, and helped to initiate intervention trials in individuals at risk for developing Insulin Dependent Diabetes Mellitus, patients with sytemic vasculitis, and patients with immunodeficiency diseases. In 1999 Dr. Dickler became the Associate Dean for Research and Graduate Studies and Professor of Medicine at the University of Maryland School of Medicine. In 2003 he was promoted to Senior Associate Dean. In this position he had primary responsibility for the school’s research enterprise, which generated $344.6 Million in research grants and contracts in FY 2005. This represented more than 50% of the School of Medicine budget, and an increase in six years of 150% from the $138.1 Million for FY 1999 prior to his arrival. Under Dr. Dickler’s leadership, Maryland rose from 39th in NIH funding among medical schools in FY 1999 to 25th in FY 2005.
His initiatives secured nearly $70 Million in NIH funding, including a Center of Excellence in Bioterrorism. Dr. Dickler joined the Association of American Medical Colleges in 2005 as the Director for Clinical Research in the Division of Biomedical and Health Sciences Research. He was principal staff for Clinical Research Task Force II, which issued its recommendations in 2006, and he succeeded in implementing several of those recommendations, and spearheaded efforts to improve informed consent documents. Dr. Dickler joined CHI in 2009 as Chief Operating Officer to help CHI reach its goals and fulfill its mission.
Last Updated July 2010